Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo

Breast Cancer Research

Volumn 14, Issue 3, 2012, Pages

  Holen, Ingunn ^a   Whitworth, Jacob ^a   Nutter, Faith ^a   Evans, Alyson ^a   Brown, Hannah K ^a   Lefley, Diane V ^a   Barbaric, Ivana ^b   Jones, Mark ^b   Ottewell, Penelope D ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; PLAKOGLOBIN; JUP PROTEIN, MOUSE; SMALL INTERFERING RNA;

ARTICLE; BONE LESION; BREAST CANCER; CANCER INVASION; CELL ADHESION; CELL CONTACT; CELL COUNT; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MICRO-COMPUTED TOMOGRAPHY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RNA SEQUENCE; TUMOR GROWTH; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL COMMUNICATION; CELL MOTION; CELL STRAIN MCF 7; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR EMBOLISM;

ANIMALS; CELL ADHESION; CELL COMMUNICATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GAMMA CATENIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MCF-7 CELLS; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASTIC CELLS, CIRCULATING; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84861373281     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3201     Document Type: Article

References (42)

1. Coleman RE. The role of bisphosphonates in breast cancer. Breast 2004, 13:S19-S28. 10.1016/j.breast.2004.09.004, 15585379.
2. Woelfle U, Cloos J, Sauter G, Riethdorf L, Jänicke F, van Diest P, Brakenhoff R, Pantel K. Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res 2003, 63:5679-5684.
3. Shafiei F, Rahnama F, Pawella L, Mitchell MD, Gluckman PD, Lobie PE. DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells. Oncogene 2008, 27:2602-2612. 10.1038/sj.onc.1210917, 17998942.
4. Albertsen HM, Smith SA, Mazoyer S, Fujimoto E, Stevens J, Williams B, Rodriguez P, Cropp CS, Slijepcevic P, Carlson M. A physical map and candidate genes in the BRCA1 region on chromosome 17q12-21. Nat Genet 1994, 7:472-479. 10.1038/ng0894-472, 7951316.
5. Aberle H, Bierkamp C, Torchard D, Serova O, Wagner T, Natt E, Wirsching J, Heidkämper C, Montagna M, Lynch HT. The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers. Proc Natl Acad Sci USA 1995, 92:6384-6388. 10.1073/pnas.92.14.6384, 41522, 7604000.
6. McPherson K, Steel CM, Dixon JM. ABC of breast diseases: breast cancer epidemiology, risk factors, and genetics. BMJ 2000, 321:624-628. 10.1136/bmj.321.7261.624, 1118507, 10977847.
7. McSherry EA, Donatello S, Hopkins AM, McDonnell S. Molecular basis of invasion in breast cancer. Cell Mol Life Sci 2007, 64:3201-3218. 10.1007/s00018-007-7388-0, 17957337.
8. Cowin P, Kapprell HP, Franke WW, Tamkun J, Hynes RO. Plakoglobin: a protein common to different kinds of intercellular adhering junctions. Cell 1986, 46:1063-1073. 10.1016/0092-8674(86)90706-3, 3530498.
9. Knudsen KA, Wheelock MJ. Plakoglobin, or an 83-kD homologue distinct from beta-catenin, interacts with E-cadherin and N-cadherin. J Cell Biol 1992, 18:671-679.
10. Lewalle JM, Bajou K, Desreux J, Mareel M, Dejana E, Noël A, Foidart JM. Alteration of interendothelial adherens junctions following tumor cell-endothelial cell interaction in vitro. Exp Cell Res 1997, 237:347-356. 10.1006/excr.1997.3799, 9434630.
11. Bartel DP, Chen CZ. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 2004, 5:396-400.
12. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004, 23:4051-4060. 10.1038/sj.emboj.7600385, 524334, 15372072.
13. Ndlovu MN, Van Lint C, Van Wesemael K, Callebert P, Chalbos D, Haegeman G, Vanden Berghe W. Hyperactivated NF-{kappa}B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells. Mol Cell Biol 2009, 29:5488-5504. 10.1128/MCB.01657-08, 2756884, 19687301.
14. Ouhtit A, Abd Elmageed ZY, Abdraboh ME, Lioe TF, Raj MH. In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver. Am J Pathol 2007, 171:2033-2039. 10.2353/ajpath.2007.070535, 2111125, 17991717.
15. Naik MU, Naik TU, Suckow AT, Duncan MK, Naik UP. Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion. Cancer Res 2008, 68:2194-2203. 10.1158/0008-5472.CAN-07-3057, 18381425.
16. Lu JY, Chen HC, Chu RY, Lin TC, Hsu PI, Huang MS, Tseng CJ, Hsiao M. Establishment of red fluorescent protein-tagged HeLa tumor metastasis models: determination of DsRed2 insertion effects and comparison of metastatic patterns after subcutaneous, intraperitoneal, or intravenous injection. Clin Exp Metastasis 2003, 20:121-133. 10.1023/A:1022645116030, 12705633.
17. Ottewell PD, Woodward JK, Lefley DV, Evans CA, Coleman RE, Holen I. Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone. Mol Cancer Ther 2009, 8:2821-2832. 10.1158/1535-7163.MCT-09-0462, 19789217.
18. Elmer P. Finch TV Software , http://www.geospiza.com
19. Life Technologies. , http://www.invitrogen.com
20. Ottewell PD, Brown HK, Jones M, Rogers TL, Cross SS, Brown NJ, Coleman RE, Holen I. Combination therapy inhibits development and progression of mammary tumours in immunocompetent mice. Breast Cancer Res Treat 2011,
21. Perez White B, Tonetti D. T47D/PKC{alpha} cells are nonmigratory and noninvasive in vitro despite tamoxifen resistance in vivo. Cancer Res 2009, 69:6173.
22. Gumireddy K, Sun F, Klein-Szanto AJ, Gibbins JM, Gimotty PA, Saunders AJ, Schultz PG, Huang Q. In vivo selection for metastasis promoting genes in the mouse. Proc Natl Acad Sci USA 2007, 104:6696-6701. 10.1073/pnas.0701145104, 1871848, 17420453.
23. Guise TA. Molecular mechanisms of osteolytic bone metastases. Cancer 2000, 88:2892-2898. 10.1002/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y, 10898330.
24. Wang L, Ling Y, Chen Y, Li CL, Feng F, You QD, Lu N, Guo QL. Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells. Cancer Lett 2010, 297:42-48. 10.1016/j.canlet.2010.04.022, 20580866.
25. Yang SZ, Kohno N, Yokoyama A, Kondo K, Hamada H, Hiwada K. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines. Int J Oncol 2001, 18:541-548.
26. Boissan M, De Wever O, Lizarraga F, Wendum D, Poincloux R, Chignard N, Desbois-Mouthon C, Dufour S, Nawrocki-Raby B, Birembaut P, Bracke M, Chavrier P, Gespach C, Lacombe ML. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells. Cancer Res 2010, 70:7710-7722. 10.1158/0008-5472.CAN-10-1887, 20841469.
27. Yi B, Williams PJ, Niewolna M, Wang Y, Yoneda T. Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer. Cancer Res 2002, 62:917-923.
28. Zetter BR. Adhesion molecules in tumor metastasis. Semin Cancer Biol 1993, 4:219-229.
29. Chen J, Imanaka N, Chen J, Griffin JD. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion. Br J Cancer 2010, 102:351-360. 10.1038/sj.bjc.6605486, 2816657, 20010940.
30. Derksen PW, Braumuller TM, van der Burg E, Hornsveld M, Mesman E, Wesseling J, Krimpenfort P, Jonkers J. Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice. Dis Model Mech 2011, 4:347-358. 10.1242/dmm.006395, 3097456, 21282721.
31. l Saleh S, Sharaf LH, Luqmani YA. Signalling pathways involved in endocrine resistance in breast cancer and associations with epithelial to mesenchymal transition. [Review]. Int J Oncol 2011, 38:1197-17.
32. Sihto H, Lundin J, Lundin M, Lehtimaki T, Ristimaki A, Holli K, Sailas L, Kataja V, Turpeenniemi-Hujanen T, Isola J, Heikkila P, Joensuu H. Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study. Breast Cancer Res 2011, 13:R87. 10.1186/bcr2944, 3262199, 21914172.
33. Zeljko M, Pecina-Slaus N, Martic TN, Kusec V, Beros V, Tomas D. Molecular alterations of E-cadherin and beta-catenin in brain metastases. Front Biosci 2011, 3:616-624.
34. Paredes J, Correia AL, Ribeiro AS, Milanezi F, Cameselle-Teijeiro J, Schmitt FC. Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival. J Clin Pathol 2008, 61:856-862. 10.1136/jcp.2007.052704, 18381381.
35. Park D, Kåresen R, Axcrona U, Noren T, Sauer T. Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis. APMIS 2007, 115:52-65. 10.1111/j.1600-0463.2007.apm_524.x, 17223851.
36. Robles-Frías A, González-Cámpora R, Martínez-Parra D, Robles-Frías MJ, Vázquez-Cerezuela T, Otal-Salaverri C, Almeida-González C. Robinson cytologic grading in invasive ductal carcinoma of the breast: correlation with E-cadherin and alpha-, beta- and gamma-catenin expression and regional lymph node metastasis. Acta Cytol 2006, 50:151-157. 10.1159/000325924, 16610682.
37. Esposito NN, Chivukula M, Dabbs DJ. The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: an immunohistochemical and clinicopathologic study. Mod Pathol 2007, 20:130-138. 10.1038/modpathol.3800721, 17143261.
38. Lionel L, Alfonso B. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene 2005, 24:7443-7454. 10.1038/sj.onc.1209091, 16288291.
39. Elston MS, Gill AJ, Conaglen JV, Clarkson A, Cook RJ, Little NS, Robinson BG, Clifton-Bligh RJ, McDonald KL. Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas. Endocrine Res 2009, 94:1436.
40. Ottewell PD, Coleman RE, Holen I. From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies. Breast Cancer Res Treat 2006, 96:101-113. 10.1007/s10549-005-9067-x, 16319986.
41. Ottewell PD, Deux B, Mönkkönen H, Cross S, Coleman RE, Clezardin P, Holen I. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo. Clin Cancer Res 2008, 14:4658-4666. 10.1158/1078-0432.CCR-07-1545, 18628481.
42. Mundy GR. Mechanisms of bone metastasis. Cancer 1997, 80:1546-1556. 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I, 9362421.